Skip to main content
Premium Trial:

Request an Annual Quote

Stefan Mullner, Christopher Huls, Tom Beil

Protagen last week announced that Stefan Müllner has replaced Christopher Hüls as the company’s CEO. Hüls left for personal reasons and will take a new position at an undisclosed pharmaceutical firm. Müllner had been Protagen’s CSO. He is a co-founder of Protagen.

SAFC, part of the Sigma-Aldrich Group, said this week that Tom Beil was appointed vice president of quality and regulatory affairs, effective July 21.
He will lead SAFC’s quality assurance team and oversee all aspects of the company’s regulatory and quality assurance programs. Beil was previously at Centocor/GBSC where he was senior director of site quality. Prior to that, he was associate director of quality assurance at Wyeth. He also was at Sigma-Aldrich from 1986 to 1999 as quality systems manager.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.